AbbVie logo

AbbVie Income Statement

Revenue, expenses, and profitability over time

AbbVie generated $62.8B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $3.6B with a 5.79% net margin. Gross margin stands at 70.68% and operating margin at 24.41%. Diluted EPS is $2.03, which declined 0.1% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-08
Market Cap$369.98B
P/E Ratio101.78
ROE-139.97%

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense-$2.2B$372.0M$613.0M$526.0M$853.0M$342.0M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income-$22.0M$1.3B$938.0M$186.0M$1.8B$695.0M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$15.1B$13.3B$15.4B$15.8B$16.6B$15.0B